Anticancer Effects of Combined γ-Tocotrienol and PPARγ-Antagonist Treatment Are Associated With a Suppression in Adipogenic Factor Expression. J. Pharm. Nutr. Sci. 2014, 4 (1), 43-56. https://doi.org/10.6000/1927-5951.2014.04.01.7.